Schedule 13D ownership disclosure

CIDARA THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 171757206

Event date: 2026-01-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.Reported CIK 0001346824

    Shares: 0.00 · Class: 0.0%

  • Peter KolchinskyReported CIK 0001384859

    Shares: 0.00 · Class: 0.0%

  • Rajeev ShahReported CIK 0001619841

    Shares: 0.00 · Class: 0.0%

  • RA Capital Healthcare Fund, L.P.Reported CIK 0001315082

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001346824-26-000004
Form type
SCHEDULE 13D/A
Filer
Cidara Therapeutics, Inc.
CIK
CIK 1610618
Filed
Jan 09, 2026
Reporting period
Jan 07, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub